Silicon Laboratories Inc. (NASDAQ:SLAB) Shares Sold by BNP Paribas Financial Markets

BNP Paribas Financial Markets lessened its stake in shares of Silicon Laboratories Inc. (NASDAQ:SLAB) by 61.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 9,225 shares of the semiconductor company’s stock after selling 14,993 shares during the quarter. BNP Paribas Financial Markets’ holdings in Silicon Laboratories were worth $1,146,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of SLAB. Capital Research Global Investors raised its position in Silicon Laboratories by 23.3% during the 4th quarter. Capital Research Global Investors now owns 2,131,920 shares of the semiconductor company’s stock worth $264,827,000 after buying an additional 403,010 shares during the last quarter. Norges Bank acquired a new stake in Silicon Laboratories in the 4th quarter valued at about $34,622,000. Invesco Ltd. boosted its stake in shares of Silicon Laboratories by 46.9% during the 4th quarter. Invesco Ltd. now owns 595,382 shares of the semiconductor company’s stock worth $73,958,000 after purchasing an additional 190,085 shares during the last quarter. Raymond James Financial Inc. acquired a new stake in shares of Silicon Laboratories during the 4th quarter worth about $14,252,000. Finally, Alliancebernstein L.P. boosted its position in shares of Silicon Laboratories by 58.2% in the fourth quarter. Alliancebernstein L.P. now owns 240,321 shares of the semiconductor company’s stock worth $29,853,000 after acquiring an additional 88,438 shares during the last quarter.

Insider Buying and Selling

In related news, CEO Robert Matthew Johnson sold 5,879 shares of the firm’s stock in a transaction on Friday, May 16th. The stock was sold at an average price of $131.20, for a total value of $771,324.80. Following the completion of the transaction, the chief executive officer now directly owns 73,688 shares of the company’s stock, valued at $9,667,865.60. This trade represents a 7.39% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Robert J. Conrad sold 1,172 shares of the stock in a transaction on Tuesday, May 13th. The stock was sold at an average price of $130.00, for a total value of $152,360.00. Following the transaction, the senior vice president now owns 15,972 shares of the company’s stock, valued at $2,076,360. This represents a 6.84% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 11,626 shares of company stock worth $1,509,319. Insiders own 1.60% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have weighed in on SLAB shares. KeyCorp lifted their price target on shares of Silicon Laboratories from $115.00 to $160.00 and gave the company an “overweight” rating in a research report on Wednesday, January 22nd. Susquehanna boosted their price objective on shares of Silicon Laboratories from $100.00 to $110.00 and gave the company a “neutral” rating in a research report on Wednesday, May 14th. StockNews.com raised shares of Silicon Laboratories from a “sell” rating to a “hold” rating in a research note on Wednesday, May 14th. Barclays reduced their price objective on shares of Silicon Laboratories from $120.00 to $80.00 and set an “equal weight” rating for the company in a report on Tuesday, April 22nd. Finally, Stifel Nicolaus cut their price target on shares of Silicon Laboratories from $145.00 to $120.00 and set a “buy” rating for the company in a report on Thursday, April 17th. Four analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $126.50.

Silicon Laboratories Price Performance

Shares of SLAB opened at $128.50 on Wednesday. The company has a market capitalization of $4.19 billion, a price-to-earnings ratio of -21.63 and a beta of 1.36. Silicon Laboratories Inc. has a fifty-two week low of $82.82 and a fifty-two week high of $160.00. The business’s 50-day moving average is $109.00 and its 200-day moving average is $121.41.

Silicon Laboratories (NASDAQ:SLAB) last released its quarterly earnings data on Tuesday, May 13th. The semiconductor company reported ($0.08) EPS for the quarter, topping analysts’ consensus estimates of ($0.09) by $0.01. Silicon Laboratories had a negative return on equity of 10.46% and a negative net margin of 32.69%. The firm had revenue of $177.71 million for the quarter, compared to the consensus estimate of $177.48 million. During the same quarter in the prior year, the company posted ($0.92) earnings per share. The firm’s revenue was up 67.0% on a year-over-year basis. Equities research analysts expect that Silicon Laboratories Inc. will post -0.97 earnings per share for the current fiscal year.

Silicon Laboratories Company Profile

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.